• Something wrong with this record ?

CZecking heart failure in patients with advanced chronic kidney disease (Czech HF-CKD): Study protocol

J. Malik, A. Valerianova, SS. Pesickova, Z. Hruskova, V. Bednarova, P. Michalek, V. Polakovic, V. Tesar

. 2024 ; 25 (1) : 294-302. [pub] 20220608

Language English Country United States

Document type Clinical Trial Protocol, Journal Article

BACKGROUND: Heart failure (HF) is a frequent cause of morbidity and mortality of end-stage kidney disease (ESKD) patients on hemodialysis. It is not easy to distinguish HF from water overload. The traditional HF definition has low sensitivity and specificity in this population. Moreover, many patients on hemodialysis have exercise limitations unrelated to HF. Therefore, we postulated two new HF definitions ((1) Modified definition of the Acute Dialysis Quality Improvement working group; (2) Hemodynamic definition based on the calculation of the effective cardiac output). We hypothesize that the newer definitions will better identify patients with higher number of endpoints and with more advanced structural heart disease. METHODS: Cohort, observational, longitudinal study with recording predefined endpoints. Patients (n = 300) treated by hemodialysis in six collaborating centers will be examined centrally in a tertiary cardiovascular center every 6-12 months lifelong or till kidney transplantation by detailed expert echocardiography with the calculation of cardiac output, arteriovenous dialysis fistula flow volume calculation, bio-impedance, and basic laboratory analysis including NTproBNP. Effective cardiac output will be measured as the difference between measured total cardiac output and arteriovenous fistula flow volume and systemic vascular resistance will be also assessed non-invasively. In case of water overload during examination, dry weight adjustment will be recommended, and the patient invited for another examination within 6 weeks. A composite major endpoint will consist of (1) Cardiovascular death; (2) HF worsening/new diagnosis of; (3) Non-fatal myocardial infarction or stroke. The two newer HF definitions will be compared with the traditional one in terms of time to major endpoint analysis. DISCUSSION: This trial will differ from others by: (1) detailed repeated hemodynamic assessment including arteriovenous access flow and (2) by careful assessment of adequate hydration to avoid confusion between HF and water overload.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24007855
003      
CZ-PrNML
005      
20240423160334.0
007      
ta
008      
240412s2024 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1177/11297298221099843 $2 doi
035    __
$a (PubMed)35676802
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Malik, Jan $u Third Department of Internal Medicine, General University Hospital and First Faculty of Medicine, Charles University, Prague, Czech Republic $1 https://orcid.org/0000000223863293 $7 xx0060338
245    10
$a CZecking heart failure in patients with advanced chronic kidney disease (Czech HF-CKD): Study protocol / $c J. Malik, A. Valerianova, SS. Pesickova, Z. Hruskova, V. Bednarova, P. Michalek, V. Polakovic, V. Tesar
520    9_
$a BACKGROUND: Heart failure (HF) is a frequent cause of morbidity and mortality of end-stage kidney disease (ESKD) patients on hemodialysis. It is not easy to distinguish HF from water overload. The traditional HF definition has low sensitivity and specificity in this population. Moreover, many patients on hemodialysis have exercise limitations unrelated to HF. Therefore, we postulated two new HF definitions ((1) Modified definition of the Acute Dialysis Quality Improvement working group; (2) Hemodynamic definition based on the calculation of the effective cardiac output). We hypothesize that the newer definitions will better identify patients with higher number of endpoints and with more advanced structural heart disease. METHODS: Cohort, observational, longitudinal study with recording predefined endpoints. Patients (n = 300) treated by hemodialysis in six collaborating centers will be examined centrally in a tertiary cardiovascular center every 6-12 months lifelong or till kidney transplantation by detailed expert echocardiography with the calculation of cardiac output, arteriovenous dialysis fistula flow volume calculation, bio-impedance, and basic laboratory analysis including NTproBNP. Effective cardiac output will be measured as the difference between measured total cardiac output and arteriovenous fistula flow volume and systemic vascular resistance will be also assessed non-invasively. In case of water overload during examination, dry weight adjustment will be recommended, and the patient invited for another examination within 6 weeks. A composite major endpoint will consist of (1) Cardiovascular death; (2) HF worsening/new diagnosis of; (3) Non-fatal myocardial infarction or stroke. The two newer HF definitions will be compared with the traditional one in terms of time to major endpoint analysis. DISCUSSION: This trial will differ from others by: (1) detailed repeated hemodynamic assessment including arteriovenous access flow and (2) by careful assessment of adequate hydration to avoid confusion between HF and water overload.
650    _2
$a lidé $7 D006801
650    12
$a srdeční selhání $x diagnóza $x etiologie $x terapie $7 D006333
650    12
$a chronické selhání ledvin $x diagnóza $x terapie $x komplikace $7 D007676
650    _2
$a longitudinální studie $7 D008137
650    _2
$a dialýza ledvin $x škodlivé účinky $7 D006435
650    12
$a chronická renální insuficience $x komplikace $7 D051436
650    _2
$a voda $7 D014867
650    _2
$a pozorovací studie jako téma $7 D064887
651    _2
$a Česká republika $7 D018153
655    _2
$a protokol klinické studie $7 D000078325
655    _2
$a časopisecké články $7 D016428
700    1_
$a Valerianova, Anna $u Third Department of Internal Medicine, General University Hospital and First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Pesickova, Satu Sinikka $u B. Braun Avitum, Dialysis Center Ohradni, Prague, Czech Republic $u Department of Nephrology, General University Hospital and First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Hruskova, Zdenka $u Department of Nephrology, General University Hospital and First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Bednarova, Vladimira $u Department of Nephrology, General University Hospital and First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Michalek, Pavel $u Department of Anaesthesiology and Intensive Medicine, General University Hospital and First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Polakovic, Vladimir $u Internal Department Strahov, General University Hospital and First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Tesar, Vladimir $u Department of Nephrology, General University Hospital and First Faculty of Medicine, Charles University, Prague, Czech Republic
773    0_
$w MED00181745 $t The journal of vascular access $x 1724-6032 $g Roč. 25, č. 1 (2024), s. 294-302
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35676802 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240412 $b ABA008
991    __
$a 20240423160330 $b ABA008
999    __
$a ok $b bmc $g 2081706 $s 1217622
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 25 $c 1 $d 294-302 $e 20220608 $i 1724-6032 $m The journal of vascular access $n J Vasc Access $x MED00181745
LZP    __
$a Pubmed-20240412

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...